DAWES KAREN A 4
4 · REPLIGEN CORP · Filed May 22, 2023
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
DAWES KAREN A
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-18+1,730→ 1,730 totalExercise: $156.63From: 2024-05-18Exp: 2033-05-18→ Common Stock (1,730 underlying) - Award
Common Stock
2023-05-18+798→ 77,199 total
Footnotes (2)
- [F1]Ms. Dawes was awarded 798 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.